The efficacy of Choep chemotherapy regimen administered in association with monoclonalantibody anti-CD52 Alemtuzumab in cutaneous T-celllymphoma (CTCL) and systemic T-celllymphoma with cutaneous involvement (PTCL)
Authors: Postorino M, De Santis G, Marchesi F, Provenzano I, Franceschini L, Pupo L, Rizzo M, Giannì L, Gumenyuk S, Tonialini L, Fiorelli E, Renzi D, Zizzari A.
Date: 2013
Scope of interest: Haematology
